Stock research
MIST Milestone Pharmaceuticals Inc.
Healthcare • Biotechnology
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an...…
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and therapeutic applications in humans. The company was founded in 2003.
3M change
-38.83%
Range high
$1.97
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in MIST?
Price
Showing 3M history. Source: FMP historical price full.
- Prev Close
- $1.17
- Day High
- $1.20
- Day Low
- $1.13
- 52w High
- $3.06
- 52w Low
- $1.00
- Volume
- 600,805
- Avg Volume
- Beta
- 0.971
* TTM/most recent where available
Company
- Ticker
- MIST
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- CA
- CEO
- Joseph G. Oliveto
- Employees
- 38
- Website
- www.milestonepharma.com
Key Metrics
- Market Cap
- 98.3M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).